Most Recent
Novartis loses appeal over patent for heart drug Entresto
Intellectual Property 2025-03-24 11:50 pm By Cat Fredenburgh

Pharmacor will be allowed to sell a generic version of heart drug Entresto after the Full Court rejected Swiss drug giant Novartis’ appeal of a ruling that found an extension of the term of its patent for the drug was invalidly granted.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

High Court must solve honest concurrent user ‘conundrum’, Cantarella says in ‘Oro’ appeal
Appeals 2025-03-17 5:51 pm By Cat Fredenburgh

Vittoria Cantarella has taken the fight to revive its ‘Oro’ trade marks to the High Court, arguing the Full Court should have found it was an honest concurrent user of the marks, which were first used by another coffee maker.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Bayer can’t get High Court to hear Xarelto patent fight
Intellectual Property 2025-03-07 11:10 pm By Christine Caulfield

The High Court won’t hear Bayer’s appeal of an invalidity finding over patents for blood thinner Xarelto, despite the company’s claim the decision has “profound” consequences for drug R&D.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Cantarella loses bid to revive ‘Oro’ trade mark
Intellectual Property 2025-02-14 11:43 pm By Andy Sidler

The Full Court has poured cold water on Vittoria Cantarella’s hopes of reviving its ‘Oro’ trade marks, finding a judge did not err in concluding the marks were already used by another coffee maker.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Novartis appeals IP win for Pharmacor over blood pressure drug
Appeals 2025-01-20 11:42 pm By Christine Caulfield

Pharmaceutical giant Novartis is challenging the loss of its case against Sydney-based generics company Pharmacor over a patent for heart medication Entresto.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

‘What’s done is done’: Judge defers penalty hearing in Harvey Norman case
Competition & Consumer Protection 2025-01-17 3:04 pm By Sam Matthews

A judge has deferred the question of what penalties Harvey Norman and Latitude Finance should face in a case by ASIC until their appeals are heard, noting the “regrettable” fragmentation of the case. 

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Katy Perry wins appeal in trade mark fight with Aussie designer
Intellectual Property 2024-11-22 11:55 pm By Sam Matthews

The Full Court has overturned a finding that singer Katy Perry infringed an Australian fashion designer’s ‘Katie Perry’ mark, finding the designer knew of the pop star when she registered the mark.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

CBA slams class actions’ ‘misguided’ theory on appeal
Class Actions 2024-11-19 11:03 pm By Sam Matthews

CBA has attacked two failed class actions’ “misguided” appeal, arguing that requiring companies to disclose incomplete information to shareholders would distort the market.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Novartis loses case against Pharmacor over blood pressure drug
Intellectual Property 2024-11-13 11:44 pm By Sam Matthews

Swiss pharmaceutical giant Novartis has lost its patent infringement case against Sydney-based generics company Pharmacor over a top-selling heart medication.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Bayer’s patents for blockbuster blood thinner Xarelto invalid: court
Intellectual Property 2024-10-23 11:45 pm By Sam Matthews

Bayer has lost its battle to protect top-selling blood thinner Xarelto from generic competition, with the Full Court finding two patents for the drug are invalid.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?